Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5577627 | 0.89 | GAA (0.48) | GAAALDH1A1CHRM3SMN1; SMN2LMNA | |
| SCHEMBL5577668 | 0.87 | PDE4A (0.52) | GAAKCNH2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5577432 | 0.87 | PRKAA2 (0.47) | KCNH2CHRM3MCHR1CXCR3 | |
| SCHEMBL5577848 | 0.86 | LMNA (0.45) | KCNH2ALDH1A1CHRM3LMNAPOLB | |
| SCHEMBL5577460 | 0.86 | CHRM3 (0.50) | GAAKCNH2ALDH1A1CHRM3SMN1; SMN2 | |
| SCHEMBL5577794 | 0.85 | GAA (0.44) | GAAKCNH2SMN1; SMN2LMNAMAPT | |
| SCHEMBL5577728 | 0.83 | GAA (0.44) | GAAKCNH2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5577323 | 0.83 | KCNH2 (0.46) | GAAKCNH2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5577287 | 0.83 | ACKR3 (0.48) | GAAKCNH2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL5577317 | 0.81 | GAA (0.51) | GAAALDH1A1CHRM3SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043079-A1 | Heterocyclic compound containing nitrogen atom and use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043079-A1 | Heterocyclic compound containing nitrogen atom and use thereof | HLA-DRB1, MIF, HLA-C | GAA 3806/4885KCNH2 3617/4885ALDH1A1 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.